Company Analysis

Jade Biosciences, Inc. (JBIO)

Nasdaq: JBIO · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2020
Grade5.0
◀ Past 5.0● Present 5.2▶ Future 4.9
7 est.

Filings

243 filings since 2017 beside 266 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.

Filings a yearinsider forms included
265631021139965
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Jun 26, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest May 1, 2025.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Oct 17, 2024.SEC letters: 15 in the last 36 months, the newest May 13, 2026.
Insider forms 266

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 28, 2026 SCHEDULE 13G Large holder notice
Oct 27, 2026 SCHEDULE 13G Large holder notice
Sep 30, 2026 8-K item 8.01 Other event · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 17, 2026 SCHEDULE 13G Large holder notice
Jul 8, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 1, 2026 8-K item 1.01 Major agreement signed · Current report Jun 29, 2026
Jun 26, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Jun 25, 2026
Jun 11, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report Jun 8, 2026
Jun 9, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 5, 2026 DEFA14A Extra proxy material
Jun 4, 2026 8-K items 8.01, 9.01 Other event · Current report Jun 3, 2026
Jun 4, 2026 424B5 Shelf offering
Jun 3, 2026 424B5 Shelf offering
Jun 1, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 15, 2026 EFFECT Registration effective
May 15, 2026 EFFECT Registration effective
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 15, 2026 424B3 Shelf offering
May 13, 2026 CORRESP Reply to the SEC
May 13, 2026 CORRESP Reply to the SEC
May 13, 2026 UPLOAD SEC comment letter
May 13, 2026 UPLOAD SEC comment letter
May 7, 2026 S-8 Employee stock plan registration
May 7, 2026 S-3 Shelf registration
May 7, 2026 S-3 Shelf registration
May 7, 2026 424B3 Shelf offering
May 7, 2026 424B3 Shelf offering
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 28, 2026 DEFA14A Extra proxy material
Apr 28, 2026 DEF 14A Proxy statement Jun 9, 2026
Apr 27, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 22, 2026 8-K item 5.02 Officer or director change · Current report Apr 18, 2026
Apr 17, 2026 PRE 14A Preliminary proxy statement Jun 9, 2026
Apr 2, 2026 8-K item 5.02 Officer or director change · Current report Mar 31, 2026
40 of 243 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton JBIO · research, not advice